reason
canin
coronaviru
ccv
grow
effici
felin
coronaviru
cell
cultur
mutual
relat
antigen
enzymelink
immunosorb
assay
elisa
use
ccvinfect
felin
kidney
crfk
cell
substrat
antigen
develop
detect
anticoronaviru
antibodi
cat
indispens
gener
coronavirusspecif
elisa
antibodi
activ
sampl
appli
mockinfect
normal
crfk
cell
parallel
ccvinfect
cell
optic
densiti
valu
given
mockinfect
cell
antigen
subtract
given
virusinfect
cell
antigen
basi
elisa
antibodi
titer
obtain
sera
cat
experiment
infect
ccv
spontan
felin
infecti
periton
fip
case
elisa
describ
present
studi
found
applic
simpl
easi
serolog
test
abl
detect
anticoronaviru
antibodi
effici
indirect
immunofluoresc
assay
homolog
fip
viru
que
coronaviru
canin
cvc
prolif
e
en
cultur
cellulair
avec
une
meilleur
que
coronaviru
et
quil
ont
une
un
test
elisa
utilis
de
cellul
ffline
crfk
par
le
cvc
comm
substrata
pour
la
de
anticorp
anticoronaviraux
chez
le
chat
pour
obtenir
une
anticorp
elisa
coronavirussp
ifiqu
il
comm
indispens
que
l
hantillon
soit
aux
cellul
crfk
normal
non
inf
en
avec
le
cellul
cidessu
et
que
le
valeur
de
optiqu
par
de
cellul
soient
soustrait
fi
cell
par
de
cellul
en
se
basant
sur
le
titr
danticorp
elisa
obtenu
avec
le
de
chat
infect
exp
imental
avec
le
cvc
ou
atteiut
de
infectieus
pif
spontan
ielisa
rit
dan
cett
ude
sest
applic
comm
un
test
fi
la
foi
simpl
et
maniabl
qui
nou
permet
de
anticorp
anticoronaviru
aussi
effectiv
que
lessai
dimmunofluoresc
indirect
avec
le
viru
pif
homoloqu
motsclef
coronaviru
viru
de
la
infectieus
coronaviru
canin
test
immunopenzymatiqu
elisa
correspond
address
abbrevi
ccv
canin
coronaviru
crfk
crandel
felin
kidney
dkp
primari
dog
kidney
eagl
mem
eagl
minim
essenti
medium
elisa
enzymelink
immunosorb
assay
fecv
felin
enter
coronaviru
fip
felin
infecti
periton
fipv
fip
viru
ifa
indirect
immunofluoresc
assay
malmonoclon
antibodi
mnt
microneutr
test
nu
nuserum
od
optic
densiti
pfu
plaqu
form
unit
pb
phosphat
buffer
salin
solut
tgev
transmiss
gastroenter
viru
vnt
viru
neutral
test
coronavirus
respons
wide
varieti
diseas
particular
respiratori
enter
disord
mammalian
avian
speci
felin
infecti
periton
fip
chronic
progress
immunologicallymedi
coronavir
diseas
one
import
viral
infect
cat
worldwid
occurr
increas
frequenc
felin
enter
coronaviru
fecv
caus
mild
intestin
diseas
fip
kitten
also
isol
consid
result
recombin
event
virul
fip
viru
fipv
avirul
fipv
felin
coronaviru
fipv
fecv
isol
thu
far
divid
least
two
type
accord
serolog
crossreact
canin
coronaviru
ccv
viru
neutral
test
vnt
may
least
antigen
group
fipv
monoclon
antibodi
mab
analysi
human
coronaviru
transmiss
gastroenter
viru
tgev
swine
ccv
fipv
fecv
compos
one
antigen
relat
group
famili
coronavirus
cat
inocul
ccv
tgev
elicit
immun
respons
homolog
also
heterolog
viru
speci
group
howev
incid
infect
gener
cat
popul
natur
heterolog
virus
unknown
fipv
prove
difficult
isol
propag
vitro
heterolog
serolog
assay
vnt
indirect
immunofluoresc
assay
ifa
enzymelink
immunosorb
assay
elisa
passiv
hemagglutin
test
use
antigen
relat
tgev
ccv
wide
appli
detect
anticoronaviru
antibodi
cat
recent
year
sever
felin
coronaviru
isol
cultiv
cell
cultur
led
develop
homolog
serolog
assay
purpos
present
report
evalu
elisa
use
ccvinfect
cell
antigen
coronaviru
serolog
cat
canin
coronaviru
grow
effici
felin
cell
use
virusinfect
cultur
cell
save
labori
expens
viru
purif
canin
coronaviru
design
strain
obtain
dr
masayuki
ajiki
kyotobiken
lab
kyoto
strain
origin
isol
fece
puppi
die
enteritid
manifest
diarrhea
vomit
previous
passag
time
primari
dog
kidney
dkp
cell
viru
cultur
twice
dkp
cell
crandel
felin
kidney
crfk
atcc
cell
laboratori
store
c
stock
viru
infect
titer
stock
viru
determin
plaqu
assay
describ
previous
crfk
cell
use
plaqu
assay
microneutr
test
mnt
elisa
cultur
eagl
minim
essenti
medium
eagl
mem
nissui
pharm
co
ltd
japan
contain
nuserum
nu
collabor
re
inc
usa
tryptos
phosphat
broth
difco
lab
usa
antibiot
twentythre
sera
ascit
collect
cat
clinicopatholog
suspect
fip
one
serum
ascit
thorac
fluid
ascit
patholog
confirm
spontan
fip
case
possess
specif
ifa
antibodi
yayoi
strain
fipv
list
tabl
obtain
depart
veterinari
patholog
univers
tokyo
tokyo
depart
veterinari
microbiolog
iwat
univers
iwat
respect
two
litter
convent
kitten
old
clinic
normal
seroneg
use
experi
litterm
kitten
oral
administ
x
plaqu
form
unit
pfu
viru
four
kitten
anoth
litter
receiv
x
pfu
oral
one
intramuscular
dose
tripl
viral
vaccin
panagen
fvr
cp
pitmanmoor
inc
usa
simultan
anoth
vaccin
booster
inject
week
later
vaccin
contain
mixtur
inactiv
felin
panleukopenia
viru
attenu
felin
caliciviru
felin
herpesviru
prepar
felin
cell
cultur
blood
sampl
taken
kitten
appropri
interv
period
neutral
antibodi
titer
determin
method
mnt
describ
elsewher
titer
regard
posit
crfk
cell
cell
densiti
eagl
mix
equal
volum
stock
viru
multipl
infect
pl
mixtur
dispens
well
flat
bottom
polystyren
plate
corn
glass
work
usa
describ
previous
incub
humidifi
chamber
contain
cell
fix
methanol
contain
min
well
satur
block
buffer
consist
gelatin
dulbecco
phosphat
buffer
salin
solut
pb
h
room
temperatur
block
buffer
remov
well
amount
test
sampl
serial
dilut
pb
contain
gelatin
tween
gtpb
ad
plate
incub
c
h
wash
empti
fill
tween
pb
washbottl
leav
min
process
repeat
time
freshli
dilut
horseradish
peroxidaseconjug
anticat
igg
goat
serum
cooper
biomed
inc
usa
gtpb
ad
well
kept
h
room
temperatur
plate
wash
result
read
spectrophotometr
nm
elisa
reader
type
corona
electr
co
ltd
japan
min
addit
abt
substrat
azinodi
benzylthiazolin
sulfon
disodium
salt
polysci
inc
usa
well
test
sampl
appli
mockinfect
normal
crfk
cell
parallel
virusinfect
cell
manner
optic
densiti
od
valu
given
mockinfect
cell
antigen
subtract
given
virusinfect
cell
antigen
correct
od
valu
elisa
titer
defin
reciproc
highest
serum
dilut
correct
od
valu
exceed
shown
fig
typic
titrat
curv
posit
neg
sera
drawn
elisa
titer
regard
posit
cat
manifest
clinic
sign
throughout
experi
rapid
rise
mnt
elisa
antibodi
titer
detect
cat
administ
ccv
day
shown
fig
antibodi
titer
gradual
rose
day
declin
thereaft
parallel
geometr
mean
elisa
titer
time
higher
mnt
titer
although
elisa
titer
preadministr
sera
regard
less
correct
od
valu
low
reactiv
mockinfect
normal
crfk
cell
antigen
shown
fig
reactiv
normal
crfk
cell
antigen
cat
vaccin
chang
drastic
cat
administ
parenter
vaccin
vaccin
sera
becam
reactiv
ccvinfect
cell
antigen
also
mockinfect
cell
antigen
compar
degre
howev
od
valu
dilut
serum
infect
cell
antigen
higher
control
cell
antigen
gener
specif
valu
relationship
mnt
elisa
titer
sampl
cat
suspect
fip
shown
fig
twentythre
anticcv
mnt
antibodyposit
titer
anticcv
elisa
antibodi
titer
detect
sampl
high
mnt
titer
n
proport
high
titer
elisa
antibodi
well
calcul
correl
coeffici
mnt
elisa
titer
found
r
significantli
high
elisa
antibodi
titer
detect
sampl
possess
low
neg
mnt
titer
less
tabl
show
mnt
elisa
antibodi
titer
ccv
serum
day
administr
bodi
fluid
fip
case
possess
specif
ifa
antibodi
fipv
case
elisa
titer
mnt
titer
ccv
correl
ifa
titer
homolog
fipv
howev
elisa
titer
gener
lower
ifa
titer
clinic
diagnosi
fip
gener
perform
evalu
result
physic
hematolog
examin
serum
electropholet
analysi
anticoronaviru
antibodi
test
moreov
biopsi
live
anim
necropsi
death
consid
definit
diagnosi
fip
serolog
test
howev
aid
diagnosi
anticoronaviru
antibodi
detect
fip
cat
also
cat
diseas
even
healthi
anim
test
use
routin
detect
anticoronaviru
antibodi
felin
ifa
elisa
tgev
ccv
popularli
use
target
antigen
result
present
studi
indic
elisa
use
ccvinfect
cultur
cell
antigen
save
labori
purifi
viral
antigen
prepar
detect
anticoronaviru
antibodi
cat
sera
extens
mnt
use
ccv
effici
ifa
use
homolog
fipv
howev
elisa
titer
gener
lower
obtain
ifa
shown
tabl
may
result
qualit
differ
substrat
antigen
ie
heterolog
homolog
coronavirus
cat
appli
test
report
other
histochem
serolog
assay
elisa
nonspecif
bind
globulin
associ
non
globulin
associ
serum
sampl
antigen
prepar
often
addit
problem
describ
falseposit
reaction
attribut
recent
vaccin
kind
cell
cultur
vaccin
prepar
use
cat
commonli
util
japan
well
antibodi
vaccin
ingredi
desir
viral
antigen
especi
serum
compon
tissu
culturederiv
vaccin
may
elicit
cat
parenter
inject
react
antigen
similar
compon
present
antigen
prepar
serolog
test
therefor
serum
sampl
test
parallel
neg
antigen
control
result
adjust
accordingli
kineticsbas
elisa
describ
barlough
et
al
present
studi
presum
whole
culturedcel
antigen
use
cat
sera
show
varieti
reactiv
mockinfect
normal
crfk
cell
antigen
well
indispens
gener
coronavirusspecif
activ
od
valu
given
mockinfect
cell
antigen
subtract
given
virusinfect
cell
antigen
vivo
subtl
antigen
differ
among
fipv
fecv
heterolog
coronavirus
dose
describ
although
recent
develop
competit
elisa
use
typespecif
mab
may
prove
use
distinguish
cat
infect
virul
fipv
cat
infect
avirul
felin
coronavirus
none
serolog
assay
routin
use
specif
enough
discern
viru
cat
expos
elisa
use
ccvinfect
cultur
cell
present
report
specif
determin
type
coronaviru
exposur
cat
result
indic
routin
applic
simpl
easi
serolog
test
anticoronaviru
antibodi
detect
cat
